Webinar: Identification of Antibodies against Challenging Targets using High Throughput, Multiplexed Approaches

Antibody-based therapeutics are unique in that they are specific in terms of binding to their target antigen. Evaluation of cross-species and/or epitope reactivity of antibodies during the screening phase is of high importance.

This webinar overviews:

• The evaluation of cross species reactivity of antibodies in the primary screening phase using the Intellicyt platform
• Applications of the Intellicyt platform in different phases of the drug discovery process

Complete the form below to watch this webinar.